nu-derm system normal-dry skin transformation trial is a Kit in the Human Prescription Drug category. It is labeled and distributed by Omp, Inc.. The primary component is .
| Product ID | 62032-516_0cdf898a-e571-4ff9-a7ed-dd29eb9cbd09 | 
| NDC | 62032-516 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | nu-derm system normal-dry skin transformation trial | 
| Generic Name | Hydroquinone, Octinoxate, And Zinc Oxide | 
| Dosage Form | Kit | 
| Marketing Start Date | 2012-11-07 | 
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER | 
| Labeler Name | OMP, INC. | 
| Active Ingredient Strength | 0 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2012-11-07 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | Unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2012-11-07 | 
| SPL SET ID: | 376dd650-fa5f-42a7-b974-6f538a28f7f2 | 
| Manufacturer | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 62032-522 | NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL | NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL | 
| 62032-532 | NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL | NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL | 
| 62032-510 | CONDITION AND ENHANCE SYSTEM | HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE | 
| 62032-516 | nu-derm system normal-dry | Hydroquinone, Octinoxate, and Zinc Oxide | 
| 62032-520 | NU-DERM SYSTEM NORMAL-DRY | Hydroquinone, Octinoxate, and Zinc Oxide | 
| 62032-513 | NU-DERM SYSTEM NORMAL-OILY | Hydroquinone, Octinoxate, and Zinc Oxide | 
| 62032-515 | nu-derm system normal-oily | Hydroquinone, Octinoxate, and Zinc Oxide |